IP Library Granted Patent US 10,679,519
Granted Patent B2
US 10,679,519 · App. 15/723,264 · Granted Jun 9, 2020

Flourescence training simulator

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,679,519
App. No.
15/723,264
Granted
Jun 9, 2020
Kind
B2
Abstract

A anatomical phantom is disclosed containing a pathological abnormality having fluorescing properties to simulate fluorescence training and/or the simulation of medical procedures, such as fluorescence-based methods for intraoperative visualization and image-guidance. The phantom is made of materials that mimic anatomical biomechanical properties and wherein the pathological abnormality contains fluorescing properties to fluoresce in responsive to UV light excitation. The phantom may be a standalone model or may be used in a complementary simulation kit to provide a more comprehensive training approach.

Claims (10)

1. A method of producing a pathological abnormality with fluorescing capability, the method comprising:

obtaining a mold of a pathological abnormality;

placing a formulation into the mold of the pathological abnormality;

freezing the formulation in the mold of the pathological abnormality;

thawing the formulation in the mold of the pathological abnormality; and

releasing the formulation from the mold of the pathological abnormality;

wherein a cycle of freezing the formulation in the mold of the pathological abnormality and thawing the formulation in the mold of the pathological abnormality is repeatable and pathological abnormality demolded in-between cycles.

2. The method of claim 1 , wherein the formulation comprises a polyvinyl alcohol (PVA) solution with PVA in a range of 7% to 10% and a fluorescing agent.

3. The method of claim 2 , wherein the formulation comprises fibrous material.

4. The method of claim 2 , wherein the formulation comprises at least one of: pigments, opacifers, patterns, textures or visual weights.

Assignments (3)
SECURITY INTEREST Recorded Jan 7, 2021
From: SYNAPTIVE MEDICAL INC.
To: ESPRESSO CAPITAL LTD.
Reel/Frame 054922/0791 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2020
From: SYNAPTIVE MEDICAL (BARBADOS) INC.
To: SYNAPTIVE MEDICAL INC.
Reel/Frame 054181/0599 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2020
From: KERINS, FERGAL; FERNALD, BRADLEY ALLAN; SIDDIQUI, MOHAMMAD KASHIF
To: SYNAPTIVE MEDICAL (BARBADOS) INC.
Reel/Frame 052559/0863 →